YH4808 clinical trials
Also written YH4808.
- studies test it
- 8
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How each study uses YH4808 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- YH4808
- 4
Studies by the year they started
8 studies that test it; most in 2012 (3)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses YH4808 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- The Exploration for Pharmacodynamics and Pharmacokinetics of YH4808 New Formulation in Healthy SubjectsCompletedPhase 1Yuhan CorporationNCT02176668Written as YH4808 NF 100
- AME Study of [14C]-YH4808 in Healthy Male SubjectsCompletedPhase 1Yuhan CorporationNCT01825707Written as [14C]-YH4808 200 mg
- Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH4808 After Oral Administration in Healthy Male SubjectsCompletedPhase 1Yuhan CorporationNCT01007019Written as YH4808 30mg
- Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux EsophagitisCompletedPhase 2Yuhan CorporationNCT01538849Written as YH4808 A mg
- YH4808 Postprandial PK/PD Study in Healthy SubjectsCompletedPhase 1Yuhan CorporationNCT01761513Written as YH4808
- Pharmacokinetic Drug Interaction Between YH4808 and DiclofenacCompletedPhase 1Yuhan CorporationNCT01876615Written as YH4808
- The PK and PD Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy SubjectsCompletedPhase 1Yuhan CorporationNCT01921647Written as YH4808
- Food Effect on Pharmacokinetics of YH4808 in Healthy Male SubjectsCompletedPhase 1Yuhan CorporationNCT01520012Written as YH4808 100 mg